GB0229595D0 - Methods and means - Google Patents

Methods and means

Info

Publication number
GB0229595D0
GB0229595D0 GB0229595A GB0229595A GB0229595D0 GB 0229595 D0 GB0229595 D0 GB 0229595D0 GB 0229595 A GB0229595 A GB 0229595A GB 0229595 A GB0229595 A GB 0229595A GB 0229595 D0 GB0229595 D0 GB 0229595D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0229595A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sciona Ltd
Original Assignee
Sciona Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciona Ltd filed Critical Sciona Ltd
Priority to GB0229595A priority Critical patent/GB0229595D0/en
Publication of GB0229595D0 publication Critical patent/GB0229595D0/en
Priority to PCT/GB2003/004372 priority patent/WO2004033725A2/en
Priority to AU2003285482A priority patent/AU2003285482A1/en
Ceased legal-status Critical Current

Links

GB0229595A 2002-10-08 2002-12-19 Methods and means Ceased GB0229595D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0229595A GB0229595D0 (en) 2002-12-19 2002-12-19 Methods and means
PCT/GB2003/004372 WO2004033725A2 (en) 2002-10-08 2003-10-08 Methods and means for the treatment of inflammatory disorders involving genotyping of the 5, 10- methylenetetrahydrofolate reductase (mthfr) gene
AU2003285482A AU2003285482A1 (en) 2002-10-08 2003-10-08 Methods and means for the treatment of inflammatory disorders involving genotyping of the 5, 10- methylenetetrahydrofolate reductase (mthfr) gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0229595A GB0229595D0 (en) 2002-12-19 2002-12-19 Methods and means

Publications (1)

Publication Number Publication Date
GB0229595D0 true GB0229595D0 (en) 2003-01-22

Family

ID=9949995

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0229595A Ceased GB0229595D0 (en) 2002-10-08 2002-12-19 Methods and means

Country Status (1)

Country Link
GB (1) GB0229595D0 (en)

Similar Documents

Publication Publication Date Title
ZA200603882B (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
IL175491A0 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
AU2003244310A8 (en) Inter-authentication method and device
EP1575495A4 (en) Compounds and methods
AU2003297037A8 (en) Illuminant and method
HK1088837A1 (en) Clk-peptide and slk-peptide
AU2003288387A8 (en) Droplet - deposition related methods and apparatus
HK1064159A1 (en) File-delivering method and file-delivering device
GB0217248D0 (en) Device and method
IL165112A0 (en) Variant integrinpolypeptides and thereof
GB0208928D0 (en) Methods
GB0320590D0 (en) Fixing means and methods
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
GB0204967D0 (en) Methods
AU2003264722A8 (en) Methods
GB0202213D0 (en) Methods
GB0223365D0 (en) Methods and means
GB0216755D0 (en) Methods and means
GB0216530D0 (en) Methods and means
GB0216529D0 (en) Methods and means
GB0207414D0 (en) Methods and means
GB0202774D0 (en) Methods and means
GB0229595D0 (en) Methods and means
AU2003223357A8 (en) Compounds and methods
GB0216029D0 (en) Device and method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)